apotex litigation




STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
On January 20, 2006, at the request of all parties to the Watson litigation the judge ordered that this litigation will be stayed, pending resolution of the Apotex litigation.
(RTTNews.com) - Sanofi (SNY, SNYNF.PK) and Bristol-Myers Squibb Co. (BMY) said Apotex has made payment in the amount of $442.21 million to Sanofi and Bristol-Myers Squibb to .
PLAVIX* Litigation
Jeffrey Brown While the Court in this
case addressed numerous issues, the scope of this article is limited to the issue of the intellectual property-c
Apotex's successful litigation of the Plavix� patents, comes 7 years prior to all patents expiring representing an accumulative savings to the Canadian Health Care System of over .
April 21, 2010 Eli Lilly-Apotex patent litigation comes to an end Jeffrey Brown While the Court in this case addressed numerous issues, the scope of this article is limited to .
Daiichi Sankyo, Inc. and its parent company, Daiichi Sankyo Co., Ltd, have reached an agreement with Apotex Inc. and Apotex Corp. to settle their patent litigation involving .
LOS ANGELES Aug 4 (Reuters) - Daiichi Sankyo Co Ltd (4568.T) said on Wednesday it reached a patent litigation settlement clearing the way for launch of a generic .
Justice Hughes did not allow these paragraphs and remarked that Apotex was not a party to any of the litigation referenced in those paragraphs.
Regulatory News: Meda (STO:MEDAA), through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a settlement agreement with Apotex Inc. and Apotex Corp .
Drawing all reasonable inferences in Plaintiffs' favor, it is plausible that the announcement apotex litigation of a criminal investigation into Bristol-Myers's efforts to settle the Apotex litigation .
. Circuit in October 2011 upholding the payment of damages to the companies by Apotex, represents the final phase of the Plavix patent litigation between the .
STOCKHOLM, Sweden--(Business Wire)-- Regulatory News: Meda (STO:MEDAA), through its wholly owned U.S. subsidiary, Meda Pharmaceuticals Inc., has entered into a . apotex litigation
. Meda Pharmaceuticals Inc., has entered into a settlement agreement with Apotex Inc. and Apotex Corp. (hereafter Apotex) that resolves the U.S. patent litigation between .
PRESS RELEASE 1/2
sources: condaiseatdark bleepimel trapexus perthico